+Search query
-Structure paper
Title | 5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 60, Page 7524-7538, Year 2017 |
Publish date | Aug 10, 2017 (structure data deposition date) |
Authors | Beaufils, F. / Cmiljanovic, N. / Cmiljanovic, V. / Bohnacker, T. / Melone, A. / Marone, R. / Jackson, E. / Zhang, X. / Sele, A. / Borsari, C. ...Beaufils, F. / Cmiljanovic, N. / Cmiljanovic, V. / Bohnacker, T. / Melone, A. / Marone, R. / Jackson, E. / Zhang, X. / Sele, A. / Borsari, C. / Mestan, J. / Hebeisen, P. / Hillmann, P. / Giese, B. / Zvelebil, M. / Fabbro, D. / Williams, R.L. / Rageot, D. / Wymann, M.P. |
External links | J. Med. Chem. / PubMed:28829592 |
Methods | X-ray diffraction |
Resolution | 2.7 Å |
Structure data | PDB-5oq4: |
Chemicals | ChemComp-A3W: ChemComp-SO4: ChemComp-HOH: |
Source |
|
Keywords | TRANSFERASE / PI3K / 3-kinase / lipid kinase / kinase / inhibitor / PQR309 / NCB5 |